Tamoxifen Citrate
- Product NDC
- 50090-0485
- 11-digit product format
- 500900485
- Labeler code
- 50090
- Product ID
- 50090-0485_b4e41027-4beb-46cc-b12d-38fc3b6f357d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tamoxifen Citrate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA070929
- Marketing category
- ANDA
- Marketing start
- 2011-08-15
- Substance
- TAMOXIFEN CITRATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A070929-001 | TAMOXIFEN CITRATE | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | |
| A070929-002 | TAMOXIFEN CITRATE | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A070929-001 | AB |
| A070929-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A070929-001 | TAMOXIFEN CITRATE | EQ 10MG BASE | TABLET / ORAL | AB | 2003-02-20 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A070929-002 | TAMOXIFEN CITRATE | EQ 20MG BASE | TABLET / ORAL | AB | 2003-02-20 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A070929-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A070929-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A070929-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A070929-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A070929-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A070929-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A070929-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A070929-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A070929-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A070929-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A070929-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A070929-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A070929-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A070929-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A070929-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A070929-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A070929-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A070929-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A070929-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A070929-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A070929-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A070929-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A070929-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A070929-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A070929-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A070929-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A070929-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A070929-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A070929-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A070929-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A070929-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A070929-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A070929-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A070929-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A070929-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A070929-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A070929-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A070929-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A070929-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A070929-002 | AB | 1 | 74a2ff9319b5… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tamoxifen Citrate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TAMOXIFEN CITRATE | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7FRV7310N6 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 198240 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8d731e7e-3b04-49a2-a0f6-3779422174cc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c3572c17-50b0-db2d-1012-2cc228ccf88f | Product name | 3 | 20201015 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-0485-1 | 2023-02-07 | C162847 | 48780-1 | f386c64a-044c-0266-e053-dadaa90a7c1a | Tamoxifen Citrate Tablets, USP Rx o nly |
| 50090-0485-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-044c-0266-e053-dadaa90a7c1a | Tamoxifen Citrate Tablets, USP Rx o nly |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0485-1 | Tamoxifen Citrate | 60 in 1 BOTTLE | TABLET | 60 | 13 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0485-1 | EA - Each | 50090-0485 | 4c1b1c9d-8329-4483-9679-b0cff09d7d9c | 1 | 2021-08-05 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0485 | TAMOXIFEN CITRATE TABLET [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 1 package rows | 20240201_8d731e7e-3b04-49a2-a0f6-3779422174cc.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Bryant Ranch Prepack | 8c0eb763-420a-4106-ba56-526b53a7f72b | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 070929 ANDA070929 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | A-S Medication Solutions | 8d731e7e-3b04-49a2-a0f6-3779422174cc | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 070929 ANDA070929 50090-0485 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Actavis Pharma, Inc. | 9b8a4211-120f-4981-ad69-928accb97637 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 070929 ANDA070929 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | A-S Medication Solutions | 716657e8-d809-4671-87bc-8d10ef69a071 | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | 070929 ANDA070929 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | NuCare Pharmaceuticals,Inc. | a5615dbb-3c5e-6ccc-e053-2995a90ab698 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 070929 ANDA070929 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Proficient Rx LP | bb53eeb7-83fc-469e-b9e3-df5f27bfec7b | 2022-09-01 | Boxed warning, Warnings, Adverse reactions | 070929 ANDA070929 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198240 | tamoxifen citrate 10 MG Oral Tablet | PSN | 8d731e7e-3b04-49a2-a0f6-3779422174cc | 13 |
| 198240 | tamoxifen 10 MG Oral Tablet | SCD | 8d731e7e-3b04-49a2-a0f6-3779422174cc | 13 |
| 198240 | tamoxifen 10 MG (as tamoxifen citrate 15.2 MG) Oral Tablet | SY | 8d731e7e-3b04-49a2-a0f6-3779422174cc | 13 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-0485-1 | 50090048501 | 60 TABLET in 1 BOTTLE (50090-0485-1) | 60 tablet | 2016-06-29 | 0000-00-00 | No | No | Current |